Trial intelligence / Profile preview

Omeprazole in Neonates with GERD

NCT01657578Phase 2Completed

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jun 2007
Primary completion
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2007; status: completed.

02

Drugs

omeprazole
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on NCT01657578.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01657578.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call